FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2321822934> ?p ?o ?g. }

• W2321822934 endingPage "56" @default.
• W2321822934 startingPage "50" @default.
• W2321822934 abstract "Autologous transplantation is a treatment option for relapsed childhood acute lymphoblastic leukemia (ALL) in second complete remission (CR2) when a suitable donor is not available. In an attempt to prevent relapses originating from graft leukemic contamination, the experimental protocol of in vitro purification of leukapheretic products with monoclonal antibodies (MoAbs), previously reported for adults, was adopted in 11 of 12 consecutive patients (median age, 9 years) with B cell precursor ALL in CR2 after late relapse (median, 37; range, 31-51 months after the onset) enrolled between July 1997 and July 1999 at a single pediatric center. At a median of 12 days after the mobilizing chemotherapy followed by G-CSF, a median of 13.9 (range, 5.9-18.7) x 10(6) CD34+ cells/kg were collected from each patient and a median of 7.5 (range, 4.1-12.6) x 10(6) CD34+ cells/kg underwent the purification procedure. The first step of immunorosetting allowed a one-log reduction of the total cell count, by eliminating more than 90% of the CD11b+ cells; the second step, performed after incubation with anti-CD19 MoAbs, allowed the depletion of 99% (range, 93-100) of the CD19+ cells, kept within the magnetic field of the immunodepletion column, with a median recovery of 73% (range, 55-87) of the collected CD34+ cells. Molecular analysis assessed the in vitro eradication of detectable leukemic cells. A median reinfusion of 5.2 (range, 3.2-9.1) x 10(6) CD34+ cells/kg for each patient (median viability, 90%), after conditioning with the 'TBI-VP16-CY' regimen, allowed prompt engraftment and immunological reconstitution; no patients experienced severe transplant-related toxicity or major infections. One patient relapsed 7 months after transplantation, while 10 patients are alive in clinical and molecular remission, at a median follow-up of 29 months (range, 15-40) (2-year EFS, 89%, s.e. 9). In conclusion, the procedure proved to be reproducible for pediatric purified autografting, highly efficient concerning stem cell recovery and depletion of leukemia-lineage specific cells, and promising in terms of final outcome." @default.
• W2321822934 created "2016-06-24" @default.
• W2321822934 creator A5011032951 @default.
• W2321822934 creator A5012343889 @default.
• W2321822934 creator A5019609842 @default.
• W2321822934 creator A5022620390 @default.
• W2321822934 creator A5029805362 @default.
• W2321822934 creator A5051520180 @default.
• W2321822934 creator A5055401685 @default.
• W2321822934 creator A5055854967 @default.
• W2321822934 creator A5066180999 @default.
• W2321822934 creator A5066480716 @default.
• W2321822934 creator A5068243608 @default.
• W2321822934 creator A5078858949 @default.
• W2321822934 creator A5083769556 @default.
• W2321822934 date "2001-01-01" @default.
• W2321822934 modified "2023-10-14" @default.
• W2321822934 title "Purified autologous grafting in childhood acute lymphoblastic leukemia in second remission: evidence for long-term clinical and molecular remissions" @default.
• W2321822934 cites W120762819 @default.
• W2321822934 cites W180289105 @default.
• W2321822934 cites W1894088929 @default.
• W2321822934 cites W1906935224 @default.
• W2321822934 cites W1914340996 @default.
• W2321822934 cites W1973233734 @default.
• W2321822934 cites W1994028882 @default.
• W2321822934 cites W2010546152 @default.
• W2321822934 cites W2016176753 @default.
• W2321822934 cites W2019574859 @default.
• W2321822934 cites W2019934820 @default.
• W2321822934 cites W2044008736 @default.
• W2321822934 cites W2048881897 @default.
• W2321822934 cites W2056196257 @default.
• W2321822934 cites W2070009500 @default.
• W2321822934 cites W2077693937 @default.
• W2321822934 cites W2080167725 @default.
• W2321822934 cites W2090823859 @default.
• W2321822934 cites W2151069914 @default.
• W2321822934 cites W2162992800 @default.
• W2321822934 cites W224182175 @default.
• W2321822934 cites W2259248272 @default.
• W2321822934 cites W2296850598 @default.
• W2321822934 cites W2305289606 @default.
• W2321822934 cites W2310979785 @default.
• W2321822934 cites W2321363556 @default.
• W2321822934 cites W2322155731 @default.
• W2321822934 cites W2327344899 @default.
• W2321822934 cites W2335857054 @default.
• W2321822934 cites W2342210190 @default.
• W2321822934 cites W2400758460 @default.
• W2321822934 cites W2407208193 @default.
• W2321822934 cites W2412093160 @default.
• W2321822934 cites W2418956611 @default.
• W2321822934 cites W4238048948 @default.
• W2321822934 cites W4293241248 @default.
• W2321822934 cites W43502357 @default.
• W2321822934 cites W85499428 @default.
• W2321822934 doi "https://doi.org/10.1038/sj.leu.2402004" @default.
• W2321822934 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11243399" @default.
• W2321822934 hasPublicationYear "2001" @default.
• W2321822934 type Work @default.
• W2321822934 sameAs 2321822934 @default.
• W2321822934 citedByCount "27" @default.
• W2321822934 countsByYear W23218229342013 @default.
• W2321822934 countsByYear W23218229342014 @default.
• W2321822934 countsByYear W23218229342016 @default.
• W2321822934 countsByYear W23218229342023 @default.
• W2321822934 crossrefType "journal-article" @default.
• W2321822934 hasAuthorship W2321822934A5011032951 @default.
• W2321822934 hasAuthorship W2321822934A5012343889 @default.
• W2321822934 hasAuthorship W2321822934A5019609842 @default.
• W2321822934 hasAuthorship W2321822934A5022620390 @default.
• W2321822934 hasAuthorship W2321822934A5029805362 @default.
• W2321822934 hasAuthorship W2321822934A5051520180 @default.
• W2321822934 hasAuthorship W2321822934A5055401685 @default.
• W2321822934 hasAuthorship W2321822934A5055854967 @default.
• W2321822934 hasAuthorship W2321822934A5066180999 @default.
• W2321822934 hasAuthorship W2321822934A5066480716 @default.
• W2321822934 hasAuthorship W2321822934A5068243608 @default.
• W2321822934 hasAuthorship W2321822934A5078858949 @default.
• W2321822934 hasAuthorship W2321822934A5083769556 @default.
• W2321822934 hasBestOaLocation W23218229341 @default.
• W2321822934 hasConcept C10205521 @default.
• W2321822934 hasConcept C126322002 @default.
• W2321822934 hasConcept C141071460 @default.
• W2321822934 hasConcept C159654299 @default.
• W2321822934 hasConcept C203014093 @default.
• W2321822934 hasConcept C2776694085 @default.
• W2321822934 hasConcept C2777408962 @default.
• W2321822934 hasConcept C2778461978 @default.
• W2321822934 hasConcept C2778957590 @default.
• W2321822934 hasConcept C2781107101 @default.
• W2321822934 hasConcept C28328180 @default.
• W2321822934 hasConcept C2909962599 @default.
• W2321822934 hasConcept C2911091166 @default.
• W2321822934 hasConcept C54355233 @default.
• W2321822934 hasConcept C71924100 @default.
• W2321822934 hasConcept C86803240 @default.
• W2321822934 hasConcept C90924648 @default.

• next